---
layout: default
title: Acetaldehyde Berberis Vulgaris Root Bark Caffeine 
parent: 僅模型預測 (L5)
nav_order: 91
evidence_level: L5
indication_count: 0
---

# Acetaldehyde Berberis Vulgaris Root Bark Caffeine 
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Homeopathic Multi-Ingredient Complex: No TxGNN Prediction Available

## One-Sentence Summary

This is an 18-component homeopathic multi-ingredient formula (including Berberis vulgaris, Echinacea, Pulsatilla, Sepia, Estrone, and others) with no current approval in Taiwan.
The TxGNN model did not generate any repurposing prediction for this combination — likely because no single DrugBank ID could be mapped to this multi-ingredient formula.
Without a prediction, no clinical trial or literature evidence is available through this pipeline to support evaluation.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | No approved indication found |
| Predicted New Indication | No prediction generated |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 — Model prediction only (no prediction output) |
| US Market Status | Not marketed |
| Number of NDAs | 0 |
| Recommended Decision | Hold |

---

## Why Was No Prediction Generated?

The TxGNN model operates by matching a drug's INN to a DrugBank node and then traversing the knowledge graph to identify candidate disease targets. This process requires a **single, identifiable DrugBank ID**.

The submitted drug entry is a compound of 18 heterogeneous ingredients spanning synthetic chemicals (acetaldehyde, caffeine, estrone), botanical extracts (Berberis vulgaris, Echinacea, garlic, goldenseal, Phytolacca, Pulsatilla, Lycopodium, Ferula), microbial or fungal preparations (Saccharomyces cerevisiae, Ustilago maydis), and mineral/excipient components (sodium borate, sucrose). This profile is characteristic of a **classical homeopathic combination remedy**.

Because no single DrugBank ID was resolved for this multi-ingredient formula, the TxGNN graph traversal could not be initiated. The query log confirms that the TFDA search returned 0 results and the DrugBank query returned only 1 generic result without a valid `drugbank_id`, leaving `predicted_indications` empty. Until individual active components are resolved to their respective DrugBank nodes — or the combination is registered as a single entity — repurposing prediction through this pipeline is not feasible.

---

## US Market Information

This formula has no recorded market authorizations. The TFDA query confirmed 0 licenses and no approved dosage forms or indications.

---

## Safety Considerations

Please refer to the package insert for safety information.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
The TxGNN pipeline could not process this submission because the multi-ingredient formula cannot be resolved to a single DrugBank node. There is no predicted indication, no supporting evidence, and no regulatory history to evaluate.

**To proceed, the following is needed:**

- **Component-level decomposition**: Run TxGNN separately for each pharmacologically active ingredient (e.g., berberine from Berberis vulgaris, caffeine, estrone, allicin from garlic) to identify individual repurposing signals.
- **DrugBank ID resolution**: Confirm whether any of the 18 components has a valid DrugBank entry, particularly the conventional drug components (caffeine: DB00201, estrone: DB00655).
- **Product identity clarification**: Determine the brand name, manufacturer, and intended therapeutic class of this combination to locate existing safety and efficacy documentation.
- **Regulatory scope check**: Homeopathic preparations are regulated differently from conventional drugs in most jurisdictions — confirm whether this formula falls under homeopathic product regulations, which may require a separate evaluation pathway.
- **MOA and safety data**: Once components are resolved, TFDA package inserts and DrugBank pharmacology data should be retrieved to complete the safety and mechanism-of-action analysis.
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

